Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression.

Saved in:
Bibliographic Details
Title: Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression.
Authors: Lalos A; Clarunis - University Digestive Health Care Center, St. Clara Hospital, University Hospital of Basel, Spitalstrasse 21, Basel, 4031, Switzerland. Alexandros.Lalos@clarunis.ch.; University Center for Gastrointestinal and Liver Diseases (Clarunis), University of Basel, Spitalstrasse 21, Basel, 4031, Switzerland. Alexandros.Lalos@clarunis.ch., Lovrinovic M; Clarunis - University Digestive Health Care Center, St. Clara Hospital, University Hospital of Basel, Spitalstrasse 21, Basel, 4031, Switzerland. marina.lovrinovic@spital.so.ch., Andersen K; Faculty of Medicine, University of Basel, Petersgraben 4, Basel, 4031, Switzerland., Posabella A; Faculty of Medicine, University of Basel, Petersgraben 4, Basel, 4031, Switzerland., Güth U; Faculty of Medicine, University of Basel, Petersgraben 4, Basel, 4031, Switzerland., Stadlmann S; Institute of Pathology, Kantonsspital Baden AG, Im Ergel 1, Baden, 5404, Switzerland., Delko T; Chirurgie Zentrum St. Anna, Luetzelmattstrasse 1, Lucerne, 6006, Switzerland., Droeser RA; Faculty of Medicine, University of Basel, Petersgraben 4, Basel, 4031, Switzerland., Singer G; Institute of Pathology, Kantonsspital Baden AG, Im Ergel 1, Baden, 5404, Switzerland.
Source: BMC cancer [BMC Cancer] 2026 Jul 08. Date of Electronic Publication: 2026 Jul 08.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first